KRAS and colorectal carcinoma: Chromosomal instability and additional somatic mutations in KRAS, BRAF, PIK3CA and/or inactivation of the TP53, SMAD4 and FBXW7 tumor suppressor genes collaborate to promote the progression of APC-mutant adenomatous lesions to CRC.